• Record-Setting Brain Organoid Holds Vast Medical Potential

    Bio-IT World | Science is at a “magical moment in time” where advances in brain organoid technology and artificial intelligence (AI) are converging to both speed up and derisk the entire drug development process. Human knowledge is poised to take major leaps forward with the discovery of molecular and electrophysiological disease fingerprints in laboratory-grown organoids, models of the human brain. This will change how lab-based drug testing is approached as well as usher in an era of “clinical trials in a vial” to model how the brain, and eventually the entire body, will respond to treatments before people enter studies.

    Oct 6, 2026

  • Follow the Money: Gene Therapy, Pediatric Brain Cancer CAR T, Thyroid Eye Disease

    Bio-IT World | Funding news from around the biotech space including investments in colon cancer immunotherapy, obesity RNAi, in vivo CAR T, autoimmune Tregs, hepatitis D, more.

    Oct 1, 2026

  • Sanofi Hands 20 Mature Medicines to Cheplapharm, NVIDIA Backs Verily, Roche Inks $1B Bispecifics Deal with Dualitas

    Bio-IT World | Ginkgo Bioworks builds an autonomous lab at Novo's new Waltham R&D facility; Helix will sequence one million biospecimens for Precure, the Mayo Clinic and Thermo Fisher joint venture; Ginkgo, Apheris, AbbVie and Takeda join antibody developability consortium; Oracle launches Oracle Life Sciences Data Intelligence; and more.

    Sep 30, 2026

  • AI-Powered Diagnostic Advances Organ Transplant Surveillance

    Bio-IT World | Precision medicine company CareDx has released a string of AI-driven diagnostic platforms since July of 2025 with the launch of AlloSure Plus. The patient-specific kidney transplant rejection risk prediction tool delivers actionable insights to reduce unnecessary biopsies, enable earlier treatment, and personalize care, thereby helping transplant centers improve outcomes, for which CareDx was awarded an Innovative Practices Award earlier this year at the Bio-IT World Conference & Expo.

    Sep 29, 2026